Preparation and Evaluation of Novel Anti-Obesity Immunoglobulins for Immunoprophylaxis and Therapy

Manal M. E. Ahmed¹ , Walid Nazmy² , Jakeen Eljakee³

Section:Research Paper, Product Type: Journal-Paper
Vol.6 , Issue.6 , pp.81-88, Dec-2019

Online published on Dec 31, 2019

Copyright © Manal M. E. Ahmed, Walid Nazmy, Jakeen Eljakee . This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
 

View this paper at   Google Scholar | DPI Digital Library

XML View     PDF Download

How to Cite this Paper

Abstract :
Obesity is one of the largest and fastest growing public health problems in the world. The pharmacological options for obesity treatment remain quite limited. Recently, one of the potential exciting research areas is the development of innovative therapeutic molecular vaccines and immunoglobulins. Here, we developed novel immunoglobulins against obesity containing anti-ghrelin O-acyltransferase (GOAT) IgY to block the activity of the appetite-stimulating hormone "ghrelin". Its preliminary pre-clinical evaluation was applied into 3 mice groups, (A) was fed standard pellet chow, (B) was fed a high-fat diet with metabolizable energy contents of 13% kcal from fat and (C) was fed a high-fat diet with metabolizable energy contents of 45% kcal from fat. Oral immunization with this biologics successfully induced beneficial responses that attenuated body weight gain by decreasing food intake and increasing energy expenditure. Anti-GOAT IgY is a promising approach for the treatment of obesity by oral administration but further studies are still required before entry into clinical trials as its effect on physical activity and visceral adipose tissue.

Key-Words / Index Term :
Obesity, Immunoglobulins, IgY, Pharmacotherapy, Ghrelin, Ghrelin O-acyltransferase, Oral immunization

References :
[1] D. Yach, D. Stuckler, K.D. Brownell, "Epidemiologic and economic consequences of the global epidemics of obesity and diabetes", Nat Med, Vol.12, pp.62–66, 2006.
[2] K.M. Flegal, M.D. Carroll, C.L. Ogden, L.R. Curtin, "Prevalence and Trends in Obesity Among US Adults, 1999-2008", JAMA,Vol.303, Issue.3, pp.235-241, 2010.
[3] A. Mukerjee, "Management of GERD, Obesity and PCOS Leading to Successful Conception Using the ‘Integrated Approach’", International Journal of Scientific Research in Biological Sciences, Vol.6, Issue.1, pp.141-144, 2019.
[4] A.V. Mayorov, N. Amara, J.Y. Chang, J.A. Moss, M.S. Hixon, D.I. Ruiz, M.M. Meijler, E.P. Zorrilla, K.D. Janda, "Catalytic antibody degradation of ghrelin increases whole-body metabolic rate and reduces refeeding in fasting mice", Proc Natl Acad Sci U S A, Vol.105, pp.17487-1792, 2008.
[5] R. R. Wing, D. F. Tate, A. A. Gorin, H. A. Raynor, J. L. Fava, "Self regulation program for maintenance of weight loss", N. Eng J Med, Vol.355, pp.1563-1571, 2006.
[6] M. Tschop, D.L. Smiley, M.L. Heiman, "Ghrelin induces adiposity in rodents", Nature, Vol.407, pp.908-913, 2000.
[7] M. Kojima, H. Hosoda, Y. Date, M. Nakazato, H. Matsuo, K. Kangawa, "Ghrelin is a growth-hormone-releasing acylated peptide from stomach", Nature, Vol.402, pp.656-660, 1999.
[8] J. Yang, M.S. Brown, G. Liang, N.V. Grishin, J.L. Goldstein, "Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone", Cell, Vol.132, pp.387-396, 2008.
[9] Y. Ikemori, M. Ohta, K. Umeda, F.C. Icatlo, M. Kuroki, H. Yokoyama, Y. Kodama., "Passive protection of neonatal calves against bovine coronavirus-induced diarrhea by administration of egg yolk or colostrum antibody powder", Vet Microbiol, Vol.58, pp.105-111, 1997.
[10] S. Rahman, F.C. Icatlo, N.V. Sa, "Immuno-Intervention with Immunoglobulin Y in Alimentary Tract Infections as an Alternative or Adjunct to Antimicrobials or Vaccines", Austin J Clin Med, Vol.1, Issue.3, pp.1012, 2014.
[11] H. Yokoyama, T. Hashi, K. Umeda, F.C. Icatlo, M. Kuroki, Y. Ikemori, Y. Kodama, "Effect of oral egg antibody in experimental F18+ Escherichia coli infection in weaned pigs", J Vet Med Sci, Vol.59, pp.917-921,1997.
[12] E.M. Akita, S. Nakai, "Comparison of four purification methods for the production of immunoglobulins from eggs laid by hens immunized with an enterotoxigenic E. coli strain. J Immunol Methods", Vol.160, pp.207-214, 1993.
[13] R. Chalghoumi, A. Thewis, Y. Beckers, C. Marcq, D. Portetelle, Y.J. Schneider, "Adhesion and growth inhibitory effect of chicken egg yolk antibody (IgY) on Salmonella enterica serovars Enteritidis and Typhimurium in vitro", Foodborne Pathog Dis, Vol.6, pp.593-604, 2009.
[14] M. Kuroki, Y. Ikemori, H. Yokoyama, R.C. Peralta, F.C. Icatlo, Y. Kodama, "Passive protection against bovine rotavirus-induced diarrhea in murine model by specific immunoglobulins from chicken egg yolk". Vet Microbiol, Vol.37, pp.135-146, 1993.
[15] L. Chen, D.J. Magliano, P.Z. Zimmet, "The worldwide epide-miology of type 2 diabetes mellitus: present and future perspectives", Nat Rev Endocrinol, Vol.8, pp.228-236, 2012.
[16] M.W. Schwartz, S.C. Woods, D. Porte, R.J. Seeley, D.G. Baskin, "Central nervous system control of food intake", Nature, Vol.404, pp.661-671, 2000.
[17] J.C. Halford, E.J. Boyland, J.E. Blundell, T.C. Kirkham, J.A. Harrold, "Pharmacological management of appetite expression in obesity", Nat Rev Endocrinol, Vol.6, pp. 255-269, 2010.
[18] N.S. Skolnik, D.H. Ryan, "Pathophysiology, epidemiology, and assessment of obesity in adults", J Fam Pract, Vol.63, Issue.7, pp. S3–S10, 2014.
[19] M.K. Badman, J.S. Flier, "The gut and energy balance: visceral allies in the obesity wars", Science, Vol.307, pp.1909–1914, 2005.
[20] M.D. Klok, S. Jakobsdottir, M.L. Drent, "The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review", Obes Rev, Vol.8, pp.21-34, 2007.
[21] E.P. Zorrilla, , S. Iwasaki, J.A. Moss, J. Chang, , J. Otsuji, K. Inoue, M. M. Meijler, K.D. Janda, "Vaccination against weight gain", Proc. Natl. Acad. Sci., Vol.103, Issue.35, pp. 13226–13231, 2006.
[22] E. Kellokoski, O. Kummu, R. Serpi, P. Lehenkari, O. Ukkola, Y.A. Kesäniemi, S. Hörkkö, "Ghrelin vaccination decreases plasma MCP-1 level in LDLR (-/-) - mice", Peptides, Vol.30, Issue.12, pp. 2292-2300, 2009.
[23] K. Takagi, R. Legrand, A. Asakawa, H. Amitani , M. François, N. Tennoune, M. Coëffier , S. Claeyssens, J.C. do Rego, P. Déchelotte, A. Inui, S.O. Fetissov, "Anti-ghrelin immunoglobulins modulate ghrelin stability and its orexigenic effect in obese mice and humans", Nat Commun, Vol.4, pp.2685, 2013.
[24] S.C. Lu, J. Xu, N. Chinookoswong, S. Liu, S. Steavenson, C. Gegg, D. Brankow, R.Lindberg, M. Véniant, W. Gu, "An acyl-ghrelin-specific neutralizing antibody inhibits the acute ghrelin-mediated orexigenic effects in mice", Mol Pharmacol, Vol.75, Issue.4, pp. 901-907, 2009.
[25] J.S. Zakhari, E.P. Zorrilla, B. Zhou, A.V. Mayorov, K.D. Janda, "Oligoclonal antibody targeting ghrelin increases energy expenditure and reduces food intake in fasted mice", Mol Pharm, Vol.9, Issue.2, pp.281-289, 2012.
[26] P.T. Pfluger, H. Kirchner, S. Günnel , B. Schrott , D. Perez-Tilve , S. Fu , S.C Benoit, T. Horvath, H.G. Joost , K.E. Wortley , M.W. Sleeman , M.H. Tschöp, "Simultaneous deletion of ghrelin and its receptor increases motor activity and energy expenditure", Am J Physio Gastrointest Liver Physiol, Vol.294, pp.G610 – G618, 2008.
[27] A.M. Abdou, M.M.E. Ahmed, Y. Yamashita, M. Kim, "Immunoglobulin: A Natural Way to Suppress Helicobacter pylori in Humans", Health, Vol.6, pp.781-791, 2014.
[28] V. Snow, P. Barry, N. Fitterman, A. Qaseem, K. Weiss, "Clinical efficacy assessment subcommittee of the American College of Physicians. Pharmacologic and surgical management of obesity in primary care: a clinical practice guideline from the American College of Physicians", Ann Intern Med, Vol.142, pp. 525-531, 2005.
[29] T. Azegami, Y. Yuki, S. Sawada, M. Mejima, K. Ishige, K. Akiyoshi, H. Itoh, H. Kiyono, "Nanogel-based nasal ghrelin vaccine prevents obesity", Mucosal Immunology, Vol.10, Issue.5, pp. 1351-1360, 2017.
[30] J.D. Roth, J.L. Trevaskis, V.F. Turek, D.G. Parkes, "Weighing in’ on synergy: preclinical research on neurohumoral anti- obesity combinations", Brain Res, Vol.1350, pp.86 - 94, 2010.
[31] A.M. Wren, , C.J. Small, C.R. Abbott, W.S. Dhillo, L.J. Seal, M.A. Cohen, R.L. Batterham, S. Taheri, S.A. Stanley, M.A. Ghatei, S.R. Bloom, "Ghrelin causes hyperphagia and obesity in rats", Diabetes, Vol. 50, Issue.11, pp.2540-2547, 2001.